OBJECTIVE	A randomized clinical trial was undertaken to compare the therapeutic effectiveness of idarubicin ( IDR ) to daunorubicin ( DNR ) , and both were given in combination with cytarabine ( CA ) in acute myelogenous leukemic ( AML ) patients .\